LEDERLE/P&G ZIAC LOW-DOSE COMBO APPROACH TO HYPERTENSION GAINS PUBLICITY
LEDERLE/P&G ZIAC LOW-DOSE COMBO APPROACH TO HYPERTENSION GAINS PUBLICITY at a March 7 press conference featuring U.S. Surgeon General Joycelyn Elders. The Washington, D.C. press conference was called by the Coalition for Hypertension Education and Control to release a survey on hypertension. CHEC consists of Lederle, Procter & Gamble, the Association of State and Territorial Health Officials, the National Council on the Aging, and the National Medical Association.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth